These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17766372)

  • 1. Pre-structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus.
    Chi SW; Kim DH; Lee SH; Chang I; Han KH
    Protein Sci; 2007 Oct; 16(10):2108-17. PubMed ID: 17766372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli.
    Maeng CY; Oh MS; Park IH; Hong HJ
    Biochem Biophys Res Commun; 2001 Apr; 282(3):787-92. PubMed ID: 11401532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry.
    Jürgens MC; Vörös J; Rautureau GJ; Shepherd DA; Pye VE; Muldoon J; Johnson CM; Ashcroft AE; Freund SM; Ferguson N
    Nat Chem Biol; 2013 Sep; 9(9):540-7. PubMed ID: 23851574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes.
    Glebe D; Urban S; Knoop EV; Cag N; Krass P; Grün S; Bulavaite A; Sasnauskas K; Gerlich WH
    Gastroenterology; 2005 Jul; 129(1):234-45. PubMed ID: 16012950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal myristylation of HBV preS1 domain enhances receptor recognition.
    De Falco S; Ruvo M; Verdoliva A; Scarallo A; Raimondo D; Raucci A; Fassina G
    J Pept Res; 2001 May; 57(5):390-400. PubMed ID: 11350599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide.
    Ye X; Zhou M; He Y; Wan Y; Bai W; Tao S; Ren Y; Zhang X; Xu J; Liu J; Zhang J; Hu K; Xie Y
    Sci Rep; 2016 Jul; 6():29391. PubMed ID: 27384014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.
    Blanchet M; Sureau C
    J Virol; 2007 Jun; 81(11):5841-9. PubMed ID: 17376925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing anti-HBV antibody binds to non-epitope regions of preS1.
    Chi SW; Kim J; Yi GS; Hong HJ; Ryu SE
    FEBS Lett; 2009 Sep; 583(18):3095-100. PubMed ID: 19716826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular retention of hepatitis B virus surface protein mutants devoid of amino-terminal pre-S1 sequences.
    Gallina A; De Koning A; Rossi F; Milanesi G
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():449-55. PubMed ID: 8113770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A carboxy-terminal portion of the preS1 domain of hepatitis B virus (HBV) occasioned retention in endoplasmic reticulum of HBV envelope proteins expressed by recombinant vaccinia viruses.
    Nĕmecková S; Kunke D; Press M; Nĕmecek V; Kutinová L
    Virology; 1994 Aug; 202(2):1024-7. PubMed ID: 8030203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface.
    Pontisso P; Ruvoletto MG; Tiribelli C; Gerlich WH; Ruol A; Alberti A
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():2041-5. PubMed ID: 1645141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated lymphoid cell and hepatocyte recognition site in the preS1 domain of the large woodchuck hepatitis virus envelope protein.
    Jin YM; Churchill ND; Michalak TI
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1837-46. PubMed ID: 8760435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution conformation of an immunodominant epitope in the hepatitis B virus preS2 surface antigen.
    Chi SW; Kim DH; Kim JS; Lee MK; Han KH
    Antiviral Res; 2006 Dec; 72(3):207-15. PubMed ID: 16872688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen.
    Ferrari C; Cavalli A; Penna A; Valli A; Bertoletti A; Pedretti G; Pilli M; Vitali P; Neri TM; Giuberti T
    Gastroenterology; 1992 Jul; 103(1):255-63. PubMed ID: 1377142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
    Gallina A; Gazina E; Milanesi G
    Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the critical regions in hepatitis B virus preS required for its stability.
    Lian M; Zhou X; Chen B; Li C; Gu X; Luo M; Zheng X
    J Pept Sci; 2008 Mar; 14(3):307-12. PubMed ID: 17918766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.
    Deng Q; Zhai JW; Michel ML; Zhang J; Qin J; Kong YY; Zhang XX; Budkowska A; Tiollais P; Wang Y; Xie YH
    J Virol; 2007 Apr; 81(8):4244-54. PubMed ID: 17192308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
    Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
    Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.